AG
IRON icon

Algert Global’s Disc Medicine IRON Stock Holding History

Algert Global’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.79M Buy
51,850
+29,170
+129% +$2M 0.05% 642
2026
Q1 		$1.45M Buy
+22,680
New +$1.57M 0.02% 780
2025
Q2 		– Sell
-16,337
Closed -$811K – 1254
2025
Q1 		$811K Hold
16,337
– – 0.02% 814
2024
Q4 		$1.04M Buy
16,337
+9,397
+135% +$544K 0.02% 777
2024
Q3 		$341K Buy
6,940
+1,642
+31% +$77.1K 0.01% 973
2024
Q2 		$239K Buy
+5,298
New +$180K 0.01% 1216

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Algert Global's IRON Position: Q2 2026 in Review

Algert Global increased its Disc Medicine (IRON) stake by 129% in Q2 2026, buying an estimated $2M and bringing the position to 51,850 shares worth $3.79M. The position accounts for 0.05% of the portfolio, ranked #642.

Algert Global first reported a position in IRON in Q2 2024 and has held it in 6 quarters since. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Algert Global held 51,850 shares of Disc Medicine worth $3.79M as of Q2 2026.
  • Algert Global bought 29,170 Disc Medicine shares in Q2 2026, an estimated $2M.
  • Disc Medicine made up 0.05% of Algert Global's portfolio in Q2 2026, its #642 holding.
  • Algert Global first reported a position in Disc Medicine in Q2 2024 and has held it in 6 quarters since.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.